Article ; Online: Oral antibiotics perturbation on gut microbiota after prostate biopsy.
Frontiers in cellular and infection microbiology
2022 Volume 12, Page(s) 959903
Abstract: Introduction: The use of antibiotics may induce the changes in gut microbiota. Previous studies have shown conflicting results on whether the changed gut microbiota by antibiotics can be recovered. Our study aims to investigate whether the gut ... ...
| Abstract | Introduction: The use of antibiotics may induce the changes in gut microbiota. Previous studies have shown conflicting results on whether the changed gut microbiota by antibiotics can be recovered. Our study aims to investigate whether the gut microbiota could be recovered after a single dose of oral co-amoxiclav before transrectal ultrasound-guided transperineal prostate biopsy (TPPBx) in 5 weeks' time. Methods: Fifteen patients with elevated serum prostate-specific antigen (PSA) were recruited to provide pre-antibiotic and post-antibiotic fecal samples. The V4 region of 16S rRNA was sequenced. Analysis was performed by QIIME2. Alpha- and beta-diversities were analyzed, as well as the differential enrichment by Linear discriminant analysis Effect Size (LEfSe) analysis. Results: Both the alpha- and beta-diversities of the pre- and post-antibiotic fecal samples were significantly different. Genera that are associated with alleviation of inflammation were enriched in the pre-antibiotic fecal samples, while the inflammation-associated genera were more enriched in the post-antibiotic fecal samples. Conclusion: A single dose of oral co-amoxiclav before TPPBx could have led to a change of gut microbiota that cannot be recovered in 5 weeks' time. Microbiome studies on prostate cancer patients should be cautioned on the use of post-prostate biopsy fecal sampling. Further studies should be conducted for the impact on gut microbiome for TPPBx alone. |
|---|---|
| MeSH term(s) | Amoxicillin-Potassium Clavulanate Combination/pharmacology ; Anti-Bacterial Agents/pharmacology ; Biopsy ; Feces ; Gastrointestinal Microbiome ; Humans ; Inflammation/pathology ; Male ; Prostate ; RNA, Ribosomal, 16S/genetics |
| Chemical Substances | Anti-Bacterial Agents ; RNA, Ribosomal, 16S ; Amoxicillin-Potassium Clavulanate Combination (74469-00-4) |
| Language | English |
| Publishing date | 2022-08-16 |
| Publishing country | Switzerland |
| Document type | Journal Article |
| ZDB-ID | 2619676-1 |
| ISSN | 2235-2988 ; 2235-2988 |
| ISSN (online) | 2235-2988 |
| ISSN | 2235-2988 |
| DOI | 10.3389/fcimb.2022.959903 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.